As the hong kong unit, unit a, medical block, re-emerged at the beginning of the new year 2026, the newly released hong kong unit, the medical etf (159137), was duly listed on the market today (12 january)。
At this time, there has been a rare break out of the “sixteen plus one” and a breakthrough of 4,100 points, and investors have risen in enthusiasm, while hong kong’s equity, and in particular its medical board, has been warmed up, and the hong kong’s medical etf (159137) market has been traded at this time. By virtue of its high-profile “medical” theme and its high-quality index, including its ability to trade in t+0, the industry believes that the product is expected to show positive performance once it is put on the market, both through an objective cushion and through the expectations of the market and investors。
According to publicly disclosed information, hong kong's share of medical etf (159137) was established on 31 december 2025 and has landed on the shenzhen stock exchange today (12 january). The index closely followed by the etf is the “medical health index of the central certificate port unit (932069. Csi)” and, according to wind statistics, has increased by 14. 25 per cent since the beginning of 2026 (1 january 2026-9 january 2026) (known as the “medical health index of the port unit”), reflecting the recent level of fever in the “hong kong unit health care”; moreover, the annual increase of 48. 20 per cent in the health thematic index of the hong kong equity unit (hong kong medical services index) in 2025 is a good indicator of the gradual improvement of the health sector in terms of industry and investor enthusiasm。
According to zhang, the fund manager of the hong kong unit of medical services etf (159137) indicated that the hong kong unit of medical services etf (159137) covered the four main areas of health care, namely cxo, medical commerce and services, medical devices and biopharmaceuticals, by tracking the china-certificate unit of medical services etf (tmci) etf qualification index, and that over 80 per cent of its weight was concentrated in cxo, internet medicine, high-end medical equipment, leading companies, and that the weight of the hong kong stock monopoly was more than 85 per cent in the core shares, including “a-free” unique logos such as kyoto’s health, ali’s health, etc., and thus enabled investors to take full advantage of the opportunities in the health sector。

Data from ici, as of 2025. 12. 31, are classified as ici level 3

The data are from chinaindicator, wind, as at 2025. 12. 31. The index component units above are shown only, and the units describe not as any form of investment advice, nor are they representative of any fund holding information and transactions under the administrator's umbrella
Industry analysts point out that hong kong's share of medical etf (159137) is a high-flexible etf product with high overall elasticity and high volatility, and that the “strength of the offensive” is expected to emerge in the face of rising medicine. First of all, “port equity” itself has the advantage of “medical golden track, the landscape is unique” and, by united nations standards, has since 2021 entered a deeply aging society with a large population base and rising per capita GDP, a rigid demand for health care and a vast market space for industry; at the same time, the port equity has benefited from special market positions and institutional advantages, absorbing the first batch of innovative medical track companies, such as ai medical images and surgical robots, with unique medical standards. From a breakdown of the tracks, china’s innovation drugs are rising globally, and the cxo market is expanding rapidly, with cagr reaching 26. 56 per cent in 2020-2025. At the same time, aai+ medicine is driving innovation over time, such as “ai+ medicine”, which is expected to be used in areas such as drug research and development, cancer diagnosis, medical imagery, surgical robots, and accelerating the release of commercial value. These bright visions and development potentials have provided a good impetus to follow-up performance and secondary market trends in the hong kong medical etf (159137)。
According to zhang, the fund manager of the hong kong unit of medical services etf (159137) stated that, despite having been visible for almost a year, the performance of health care in the hong kong unit had been fully adjusted over a period of four years, with the index “hong kong unit access to health theme index” still at a relatively low level and its valuation. By the end of 2025, the index points were more than 65 per cent higher than their historical highs in 2021; the municipal surplus rate (ttm) was 29. 43 times lower than the time frame of more than 65 per cent since the base date. Overall, the configurable value of the hong kong & hong kong & hong kong & west bank & hong kong & west bank & hong kong & hong kong & west bank & hong kong & hong kong & hong kong & west bank & hong kong & hong kong & west bank & hong kong & west bank & hong kong & west bank & hong kong & west bank & hong kong & west bank & hong kong & west bank & hong kong & west bank & hong kong & hong kong & west bank & hong kong & west bank & hong kong & west bank & hong kong & hong kong & west bank & hong kong & west bank & hong kong & hong kong & hong kong & west bank & hong & hong kong & hong kong & west bank & hong kong & west bank & hong kong & west bank are more prominent。
Valuation of the hong kong unit health thematic index





